Poul Erik Jakobsen

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 342 citations · Full text

Medicine, Nephrology, Pharmacology +13

Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test

Hans Christian Hoeck, Peter Vestergaard, Poul Erik Jakobsen et al. · European Journal of Endocrinology · 1995 · 124 citations

Life Sciences, Endocrinology, Hormone Biochemistry +9

Liraglutide treatment reduced interleukin‐6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy

Christina Brock, Christian Stevns Hansen, Jesper Karmisholt et al. · British Journal of Clinical Pharmacology · 2019 · 88 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile

Adam D. Farmer, Anne Grave Pedersen, Birgitte Brock et al. · Diabetologia · 2017 · 66 citations · Full text

Medicine, Internal Medicine, Neurology +8

Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users

Morten Hasselstrøm Jensen, Mads Kjølby, Ole Hejlesen et al. · Diabetes Care · 2020 · 56 citations

Medicine, Internal Medicine, Pharmacotherapy +17